Altimmune, Inc (ALT) Stock Price

3.19 ▼ -0.22 (-6.45%)
Open: 3.42 Vol: 4.52M Day's range: 3.15 - 3.425 Sep 23, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.19▲ 3.20▼ 3.19▲ 3.28▼ 3.25▼
MA10 3.20▼ 3.20▼ 3.26▼ 3.27▼ 3.10▲
MA20 3.19▲ 3.27▼ 3.28▼ 3.25▼ 2.99▲
MA50 3.20▼ 3.27▼ 3.26▼ 3.08▲ 3.63▼
MA100 3.27▼ 3.27▼ 3.28▼ 3.00▲ 4.66▼
MA200 3.28▼ 3.28▼ 3.18▲ 3.55▼ 5.88▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.010▼ -0.016▼ -0.011▼ 0.090▲
RSI 48.695▼ 40.739▼ 40.320▼ 49.173▼ 49.209▼
STOCH 30.000     29.417     9.641▼ 33.780     65.273    
WILL %R -60.000     -85.185▼ -85.185▼ -90.000▼ -44.720    
CCI -76.667     -55.415     -87.169     -64.667     86.295    
Latest Filters Detected On ALT
RSI $ALT RSI(14) Crossed Below 50 Set Alert
MA $ALT Price Crossed Below MA(26) Set Alert
MA $ALT Price Crossed Below MA(13) Set Alert
MA $ALT Price Crossed Below MA(7) Set Alert
CDL $ALT Engulfing Candlestick Pattern Detected Set Alert
Altimmune, Inc News
Altimmune’s (ALT) Three Liver Trials Move Forward At Once
Monday, September 07, 2026 07:27 PM
On August 12, Altimmune (NASDAQ:ALT) reported second quarter results that read less like a routine earnings update and more like a status check on three separate diseases at the same time. The ...
Altimmune shares jump after positive phase 2 alcohol use disorder trial results
Tuesday, July 28, 2026 05:23 AM
Altimmune Inc. (NASDAQ:ALT) shares climbed 18% on Tuesday after the biotechnology company reported positive topline data from its Phase 2 RECLAIM study evaluating pemvidutide as a treatment for ...
Leerink Sees Altimmune (ALT) As An Attractive Play In The MASH Therapeutics Market
Sunday, July 05, 2026 11:08 AM
Altimmune, Inc. (NASDAQ:ALT), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to buy right now. Fresh analyst confidence in the company’s MASH drug candidate ...
ALT historical stock data
date open high low close volume
23/09/26 3.42 3.425 3.15 3.19 4,516,300
22/09/26 3.335 3.41 3.255 3.41 3,671,807
21/09/26 3.31 3.34 3.24 3.27 3,516,200
18/09/26 3.25 3.26 3.18 3.26 3,523,793
17/09/26 3.305 3.345 3.215 3.25 3,027,460
16/09/26 3.26 3.29 3.20 3.25 2,925,813
15/09/26 3.31 3.31 3.21 3.23 2,074,902
14/09/26 3.27 3.36 3.27 3.30 2,460,900
11/09/26 3.33 3.41 3.26 3.27 2,678,900
10/09/26 3.32 3.345 3.25 3.29 2,544,800
Quote Details
52wk Low:2.56
52wk High:6.44
Vol:4.52M
Avg Vol(3m):79.8M
1Y Chng:-20.25%
1M Chng:+8.87%
Add to Watch List
More Information
Index US Composite
Market Cap. 663.31M